Augustinus Bader, the high-end skin care label, has reportedly closed a funding round of US$25m.
According to publication WWD, French businessman Antoine Arnault and model Natalia Vodianova are among the investors.
The brand, the brainchild of biomedical scientist Professor Augustinus Bader and CEO and co-founder Charles Rosier, a former Goldman Sachs MD, is also said to be exploring deal options with investment bank Centerview Partners.
Augustinus Bader’s skin care skus are based on a patented TFC8 (Trigger Factor Complex) technology of natural amino acids, high grade vitamins and synthesised molecules naturally found in the body to nourish and protect the skin.
This technology commands an impressive price tag, with 50ml of the brand’s The Rich Cream costing £215.
The brand more recently branched into hair care, and lash and eyebrow care.
Augustinus Bader affirmed its focus on innovation earlier this year by onboarding Bobbi Brown, the make-up artist and beauty industry guru, as its Chief Creative Advisor.
Commenting at the time, Brown said: “The Rich Cream was my first introduction to Professor Bader’s genius TFC8 technology and his groundbreaking approach to skin care and I’ve been hooked ever since.
“I am very excited to partner with this team to continue helping them innovate the future of beauty and wellness.”
Last month saw the brand’s first pop-up in North America, at The Grove retail destination in LA.
“We are thrilled to open the brand’s first conceptual pop-up in North America for 4 weeks in October,” said Rosier of the pop-up.
“It’s a true LA destination takeover with a modern introduction to our premium skincare and luxury wellness regimens.”
Cosmetics Business has reached out to Augustinus Bader for comment.
